V5T-32984-06877 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-15
Dose 1 — Pfizer-BioNTech
2020-12-16
Registered in v-safe
2020-12-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-18
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-19
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-22
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-04
Dose 2 — Pfizer-BioNTech
2021-01-05
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenitis — Feeling: Good · Site: Pain

Free text: Inflamed lymphatic nodule

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-06
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to work

Adult check-in
2021-01-06
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

2 call case(s)
2021-01-08
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Lymphadenopathy of axilla and supraclavivular area of side of injection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-09
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Lymphadenopathy continues but improved

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-10
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Lymphadenopathy continues

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-11
Survey response — day 7, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Lymphadenopathy continues

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-18
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-25
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-01
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-08
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-15
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-05
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-05
Survey response — 6 months, dose 2
MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion, Sneezing — Feeling: Good

Free text: Cold like symptoms (cough, congestion, sneezing)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2022-01-06
Survey response — 12 months, dose 2
MedDRA: Pelvic pain — Feeling: Poor · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Pelvic pain

MedDRA releases: 2024-11 · check-in free text available
2022-01-06
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · 1 call case(s)
2022-01-07
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-15	Pfizer-BioNTech
2	2021-01-04	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-06	priority 2/3
2021-01-06	priority 2/3
2022-01-06	Unsuccessful

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-05

Systemic reaction (other): Inflamed lymphatic nodule

2021-01-08

Systemic reaction (other): Lymphadenopathy of axilla and supraclavivular area of side of injection

2021-01-09

Systemic reaction (other): Lymphadenopathy continues but improved

2021-01-10

Systemic reaction (other): Lymphadenopathy continues

Release 1 — day 7, dose 2

2021-01-11

Systemic reaction (other): Lymphadenopathy continues

Release 9 — 6 months, dose 2

2021-07-05

Symptoms: Cold like symptoms (cough, congestion, sneezing)

Release 10 — 12 months, dose 2

2022-01-06

Symptoms: Pelvic pain

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	✓	✓	✓
SD	Nasopharyngitis	✓	✓	✓
SD	Pelvic pain	·	·	✓
SD	Respiratory tract congestion	✓	✓	✓
SD	Sneezing	✓	✓	✓
SRO	Lymphadenitis	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release